Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06546007

Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

Sponsor: Rarecells Diagnostics SAS

View on ClinicalTrials.gov

Summary

Early diagnosis of lung cancer is a public health priority. Additionally, early detection of recurrences after treatment is crucial for optimizing disease management. This study seeks to demonstrate the accuracy of the Rarecells ISET® circulating tumor cells DNA (CTC-DNA), combined with circulating tumor DNA (ctDNA), for the early diagnosis of lung cancer.

Official title: Clinical Study To Evaluate the Sensitivity of Circulating Iset® by Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

Key Details

Gender

All

Age Range

35 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2024-11-13

Completion Date

2025-10-01

Last Updated

2025-06-11

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

CTC-DNA

ctDNA for the analysis of lung cancer mutations in patients with operable tumors.

Locations (1)

Università Cattolica del Sacro Cuore Gemelli Hospital

Roma, Italy